Healthcare Industry News 21 November 2025

McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (NYSE: MCK) is ending 2025 as one of the standout performers in U.S. healthcare — but as of Wednesday, December 3, its stock is taking a breather. At the close, McKesson shares finished at $805.37, down 2.93% on

4 December 2025

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

As of December 2, 2025, CVS Health Corporation (NYSE: CVS) finds itself in a classic “good news, bad headlines” moment: the stock has pulled back after a strong 2025 rally, the company agreed to a federal settlement over insulin-pen billing,

3 December 2025

Financial Insights · Healthcare Industry · Investment Analysis · NYSE:CVS · Pharmaceutical News · Stock Market

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare, Inc. (NYSE:HCA) is ending 2025 on a powerful note. After a year of double‑digit earnings growth and upgraded guidance, HCA stock is trading just above $500 per share, close to its 52‑week high of $520 and implying a

3 December 2025

Earnings Reports · Healthcare Industry · Investment Analysis · NYSE:HCA · Policy Risks · Stock Market

Johnson & Johnson (JNJ) Stock Near Record Highs: New EU Drug Approval, Oncology Deal and 2026 Outlook

As of December 2, 2025, Johnson & Johnson (NYSE: JNJ) is trading just below all‑time highs, supported by a powerful 2025 rally, a fresh European Union drug approval, a new $3.05 billion oncology acquisition, and a planned spin‑off of its

2 December 2025

Business News · Healthcare Industry · Investing · NYSE:JNJ · Pharmaceuticals · Stock Market

CSL Limited (ASX:CSL) Stock Outlook on 2 December 2025: Share Price Slump, Seqirus Spin-Off, New Vaccine Plant and a A$750m Buyback

Updated: 2 December 2025 CSL Limited’s share price has spent most of 2025 in the sin bin, but behind the drawdown sits a mix of solid earnings growth, a radical restructuring, a forthcoming spin‑off of its vaccines arm and fresh

2 December 2025

Corporate News · CSL Limited · Healthcare Industry · Investment Analysis · Stock Market

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

Data and news current as of December 1, 2025. This article is for informational purposes only and is not financial advice. CVS Health Stock Today: A Big 2025 Comeback, Slightly Off the Highs CVS Health Corporation (NYSE: CVS) has staged

2 December 2025

Dividend Stocks · Financial Forecasts · Healthcare Industry · Investing · NYSE:CVS · Stock Market

Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences Corporation (NASDAQ: EXAS) has turned into one of the most closely watched healthcare stocks heading into December 2025, thanks to a blockbuster takeover agreement with Abbott Laboratories, strong Q3 results, and a rapid share‑price rally that has pushed

1 December 2025

Company Earnings · Healthcare Industry · Investments · Mergers & Acquisitions · NASDAQ:EXAS · NYSE:ABT · Stock Market

Abbott Laboratories (ABT) Stock Today, November 26, 2025: Insider Sale, $21B Exact Sciences Deal and Libre 3 Sensor Correction in Focus

Abbott Laboratories (NYSE: ABT) enters Wednesday, November 26, 2025 with its share price hovering around $128 after a modest gain in Tuesday’s session. Investors are weighing three main storylines: a fresh insider stock sale, the $21 billion takeover of Exact

26 November 2025

Healthcare Industry · Insider Trading · Medical Technology · Mergers & Acquisitions · NYSE:ABT · Stock Market

Merck Stock Jumps on Wells Fargo Upgrade and New Keytruda Wins – MRK Today, November 24, 2025

Merck & Co., Inc. (NYSE: MRK) is suddenly back in the market’s spotlight. On Monday, 24 November 2025, Merck’s share price surged to around $102, up roughly 4–4.5% on the day, after a bullish analyst upgrade collided with fresh regulatory

24 November 2025

Company Updates · Healthcare Industry · Investment · NYSE:MRK · Pharma News · Stock Market

Monash IVF (ASX: MVF) Share Price Soars as Board Rejects 80¢ Takeover Bid and Macquarie Sees 54% Upside

Sydney – 24 November 2025 Monash IVF Group Ltd (ASX: MVF) has surged back into the spotlight today after rejecting an 80¢-per-share takeover proposal from a private equity–backed consortium, sending the embattled fertility stock up around 40–41% to about 86¢

24 November 2025

ASX News · Healthcare Industry · Investment · Mergers & Acquisitions · Stock Market

CVS Health Stock Today (NYSE: CVS): Institutional Buying, New Board Chair and Q3 Shock Shape Outlook – November 23, 2025

CVS Health stock is heading into the new week near the top of its 2025 trading range after a year of sharp gains, a headline‑grabbing goodwill write‑down, and a wave of fresh institutional ownership filings released today, November 23, 2025.

23 November 2025

Company News · Financial Reports · Healthcare Industry · Investment Analysis · Stock Market

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk stock is back in the spotlight today, 21 November 2025, as a cluster of breaking headlines hits the world’s most closely watched weight‑loss drug maker. As of late morning in New York, Novo Nordisk’s U.S. ADR (NYSE: NVO)

21 November 2025

Financial Analysis · Healthcare Industry · Investment News · NYSE:NVO · Pharmaceuticals · Stock Market

Healthcare Industry News 21 November 2025 - 4 December 2025